Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Fungal infections can cause hair loss in lupus patients and should be considered even if rare.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Yellow dots are common in severe alopecia areata.

Adequate steroid treatment needed to limit bone loss in PMR patients.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.